Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma-Reference-Cited by-同舟云学术

Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma

Published:2010-07 Issue:2 Volume:80 Page:170-178
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Archer Crystal R.,Koomoa Dana-Lynn T.,Mitsunaga Erin M.,Clerc Jérôme,Shimizu Mariko,Kaiser Markus,Schellenberg Barbara,Dudler Robert,Bachmann André S.

Funder

Cancer Research Center of Hawaii (A.S.B.) and by the Swiss National Science Foundation

Cell and Molecular Biology Graduate Program of the University of Hawaii

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference40 articles.

1. The proteasome: structure, function, and role in the cell;Adams;Cancer Treat Rev,2003

2. Proteasome inhibitors: from research tools to drug candidates;Kisselev;Chem Biol,2001

3. The proteasome: a suitable antineoplastic target;Adams;Nat Rev Cancer,2004

4. Joining the army of proteasome inhibitors;Kisselev;Chem Biol,2008

5. Proteasome inhibition as a novel therapeutic target in human cancer;Rajkumar;J Clin Oncol,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics;Metabolites;2023-03-31

2. Disruption of c-di-GMP Signaling Networks Unlocks Cryptic Expression of Secondary Metabolites during Biofilm Growth in Burkholderia pseudomallei;Applied and Environmental Microbiology;2022-04-26

3. Pluronic F127/carfilzomib-based nanomicelles as promising nanocarriers: synthesis, characterization, biological, and in silico evaluations;Journal of Molecular Liquids;2022-01

4. Disruption of c-di-GMP signaling networks unlocks cryptic expression of secondary metabolites during biofilm growth in Burkholderia pseudomallei;2021-12-13

5. A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma;Current Topics in Medicinal Chemistry;2021-05-26